Skip to main content
Tech.euFundingExplorerBeta

Debiopharm Group

Investor profile

Deals
5
distinct rounds
Companies
5
backed
Active span
2013–2025
13 yrs
Total round €
€36M
sum of rounds joined

Deals by year

distinct rounds / year

Top sectors

by deals

Stages

by deals

Countries

by deals

Co-investment network

shared rounds
Debiopharm Group14Peaks CapitalAlven CapitalArve CapitalChristoph HaarburgerHeliadInflection.xyzJens BegemannLars LanguschPicus CapitalRubin RitterShip2B VenturesSwisscom VenturesTesiWingman VenturesZurich Cantonal Bank

Hover a node for shared-deal counts; click a co-investor to open its profile.

Portfolio

top 30 by total round €
CompanyCountryRoundsTotal €
StratifAIGermany1€13M
MikaGermany1€10M
BC PlatformsSwitzerland1€9.1M
Tune InsightSwitzerland1€3.2M
KeyLemonSwitzerland1€1.4M

Biggest deals

top 10 by amount
CompanyStageAmountDate
StratifAIOther€13M2025-09
MikaOther€10M2022-05
BC PlatformsSeries B€9.1M2017-05
Tune InsightOther€3.2M2023-09
KeyLemonSeries A€1.4M2013-08
← Back to investors